Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (12)

1

Analysis of the Efficacy and Safety of Intratymapanic Dexamethasone for Treating Meniere's Disease : A Randomized Controlled Trial

enthalten in: Ear, nose, & throat journal | 2022

von Yin, G. | Zhicheng Li | Zhang, S. | +4

2

Clinical review report : (Bausch Health, Canada Inc.) : indication : psoriasis, moderate-to-severe plaqueHalobetasol propionate and tazarotene (Duobrii)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, December 2020

CADTH common drug review

Version: Final (with redactions).

3

Inhaled corticosteroids for cystic fibrosis : a review of clinical effectiveness

Erschienen: Ottawa, CADTH, March 12, 2019

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Peprah, K. | McCormack, S.

4

Clinical review report : indication : for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and olderCrisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)

Erschienen: Ottawa (ON), CADTH, April 2019

CADTH common drug review

5

A treatise on topical corticosteroids in dermatology : use, misuse and abuse

Erschienen: Singapore, Springer, [2018]

SpringerLink, Bücher

von Lahiri, K.

6

Omalizumab (Xolair)

Erschienen: Ottawa (ON), CADTH, September 2017

Common drug review clinical review report

7

Clinical review report : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to conventional therapy including corticosteroids, azathioprine and/or 6‐mercaptopurine (6‐MP) or who are intolerant to such therapiesAdalimumab (Humira)

Erschienen: Ottawa (ON), CADTH, April 2016

CADTH common drug review

8

Mepolizumab (Nucala)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2016 Nov

Common drug review

9

Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have responded inadequately to previous therapy with disease-modifying antirheumatic drugs and systemic corticosteroids

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, [2014]

Common drug review

10

Consideration of evidence on antiemetic drugs for nausea and vomiting associated with chemotherapy or radiation therapy in adults

Erschienen: Rockville (MD), Agency for Healthcare Research and Quality (US), July 22, 2010

Technology assessment report

von McDonagh, M. | Peterson, K. | Thakurta, S.